Assessing Centrus Energy’s Valuation After Oak Ridge Expansion Plan And Reaffirmed Outperform Rating

Centrus Energy Corp. Class A +0.17% Pre

Centrus Energy Corp. Class A

LEU

183.53

183.00

+0.17%

-0.29% Pre

Oak Ridge expansion puts long term growth plans in focus

Centrus Energy (LEU) is committing more than $560 million to expand its Oak Ridge uranium enrichment centrifuge manufacturing plant, targeting high rate output with initial centrifuges expected to be running by 2029.

This large capital plan, combined with William Blair’s reaffirmed Outperform rating following mixed quarterly results, has focused investor attention on how Centrus is positioning its nuclear fuel business for the next decade.

Even with the planned Oak Ridge expansion and William Blair’s reaffirmed Outperform rating in focus, Centrus Energy’s share price return has been under pressure recently. The 30 day share price return shows a decline of 24% and the year to date share price return shows a decline of 25.48%. At the same time, the 1 year total shareholder return of 140.16% and the 3 year total shareholder return of close to 4x highlight how sentiment around its nuclear fuel exposure has shifted over a longer horizon.

If this Oak Ridge news has you thinking more broadly about nuclear fuel and infrastructure, it could be a good time to review 85 nuclear energy infrastructure stocks as potential peers to research next.

With Centrus posting mixed results, planning more than $560 million in new spending and trading at roughly a 5% intrinsic discount and 39% discount to one analyst target, you need to ask: Is this a buying opportunity, or is the market already pricing in future growth?

Most Popular Narrative: 27.4% Undervalued

The most followed narrative currently places Centrus Energy’s fair value at $279.73 versus the last close of $203.08, framing the Oak Ridge expansion inside a much bigger long term growth story.

The analysts have a consensus price target of $229.3 for Centrus Energy based on their expectations of its future earnings growth, profit margins and other risk factors. However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $310.0, and the most bearish reporting a price target of just $108.0.

Want to understand why this narrative still points to upside even with mixed views on earnings, margins and share dilution? The entire case hinges on a carefully balanced mix of growth, contracting assumptions and the profit multiple the market may eventually settle on. Curious how those moving parts connect to justify a fair value well above today’s price?

Result: Fair Value of $279.73 (UNDERVALUED)

However, stretched P/E assumptions and ongoing equity dilution could both undercut the 27.4% undervalued case if earnings or contract timing fail to meet expectations.

Another View: High P/E Puts Pressure On The Story

While our fair value model suggests Centrus trades at roughly a 5% discount, the current P/E of 51.3x is far higher than the US Oil and Gas industry at 15x, the peer average at 16.3x, and even our fair ratio of 13.3x. This raises the question of how much optimism is already priced in.

NYSE:LEU P/E Ratio as at Mar 2026
NYSE:LEU P/E Ratio as at Mar 2026

Next Steps

After all this, does the Centrus story feel balanced or skewed to you? Take a closer look at the full picture, including 3 key rewards and 3 important warning signs, and decide where you stand.

Looking for more investment ideas?

If Centrus has sharpened your focus, do not stop here, use the Simply Wall St Screener to spot fresh opportunities before they slip past you.

  • Target quality at a discount by scanning our 47 high quality undervalued stocks that combine robust fundamentals with appealing valuations.
  • Build a steadier income stream by reviewing 14 dividend fortresses that offer higher yields with an emphasis on resilience.
  • Zero in on financial strength first by checking solid balance sheet and fundamentals stocks screener (41 results) where balance sheets and core metrics do the heavy lifting.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.